The Development and Study of a 3D-Printed Model for Surgical Planning of Lung Cancer with Realistic Subsegmental Boundaries and Complete Tissue Structures

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06507774

Enrollment

150

Registered

2024-07-18

Start date

2023-01-01

Completion date

2024-01-01

Last updated

2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

This project focuses on the development of a precision multi-organ surgical planning model aided by artificial intelligence (AI), computer-aided design (CAD), multi-material 3D printing, and multimodal 3D modeling. The integration of these advanced technologies aims to enhance the accuracy and efficiency of preoperative planning for complex surgical procedures involving multiple organs. By leveraging AI and CAD, the project seeks to create detailed, patient-specific 3D models that incorporate various imaging modalities. These models will be used to guide multi-material 3D printing, producing highly accurate replicas of anatomical structures. The ultimate goal is to improve surgical outcomes by providing surgeons with precise and comprehensive tools for planning and executing intricate surgeries.

Interventions

DEVICE3D Reconstruction Technology

Utilization of 3D reconstruction technology to assist in preoperative planning and surgical procedures for thoracic surgery patients.

DEVICENo 3D reconstruction is used

This group did not use 3D reconstruction for surgical navigation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients diagnosed with lung cancer * Complete clinical case data; * All patients underwent surgical treatment; * Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

* Severe comorbidities, such as uncontrolled heart disease or diabetes * History of major surgeries or other interventions * Unwillingness to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Operation Time	During the surgery	Measure the total duration of the surgery in minutes.
Blood Loss	During the surgery	Assess the total blood loss during surgery in milliliters.
Postoperative Complications	Within 30 days post-surgery	Record any complications within 30 days post-surgery.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026